AUA 2018 Bladder Cancer

REVIEW UroToday

Viewing 1-20 of 51 articles

AUA 2018: Comparative Effectiveness of Neoadjuvant and Adjuvant Chemotherapy in the Medicare Bladder Cancer Population

AUA 2018: Bipolar Transurethral Resection of Bladder Tumor Provides Better Tissue for Histopathology but Has No Superior Efficacy and Safety

AUA 2018: Early Opioid Use in ERAS Pathway in Radical Cystectomy Correlates with Increased Length of Stay and Cost

AUA 2018: Frequency of Low Grade T1 Bladder Cancer Has Decreased but Continues to Vary by Institution

AUA 2018: FDG-Positron Emission Tomography for Assessing the Response to Neo-Adjuvant Chemotherapy in Bladder Cancer Patients

AUA 2018: Risk of Bone Fractures Following Urinary Intestinal Diversion: A Population-Based Study

AUA 2018: Predicting Chemo Sensitivity in Urothelial Malignancy: Nanotech and Precision Medicine

AUA 2018: Medium Size Bladder Tumors En-block Bipolar Resection on Put to the Test

AUA 2018: Purified Protein Derivative Skin Test Prior to BCG Therapy Enhances the Clinical Efficacy of BCG Therapy in Patients with NMIBC

AUA 2018: Correlation between Surgeon’s Experience and Pathological and Oncological Outcomes after Transurethral Resection of the Bladder

AUA 2018: Switching of Bacillus Calmette-Guerin Strain at Second BCG Therapy May Reduce BCG-Related Side Effects in Patients with BCG-Relapsing Tumors

AUA 2018: Patient Centered Outcomes of Intravesical BCG Plus Interferon

AUA 2018: Accurate Prediction of Progression to Muscle Invasive Disease in Patients with T1G3 Bladder Cancer: A Clinical Decision-Making Tool

AUA 2018: Prospective Validation of a Diagnostic Urine Test For Bladder Cancer: The HEMAturia Study

AUA 2018: Phase II Trial of Neoadjuvant Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma: Results From ECOG-ACRIN 8141

AUA 2018: Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?

AUA 2018: Survival after Segmental Resection of Distal Ureter and Termino-Terminal Ureteral Anastomosis vs Bladder Cuff Removal and Ureteral Reimplantation for Urothelial Carcinoma of the Ureter

AUA 2018: The Impact of Blue-Light Cystoscopy on Response to Induction BCG in Patients with High-Grade Non-Muscle Invasive Bladder Cancer

AUA 2018: Debate: Molecular Subtypes: Not Ready for Prime Time

AUA 2018: Debate: Molecular Profiling Influences My Treatment Selection

1
2
3